Park E, Schuller-Levis G, Quinn M R
Department of Immunology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314, USA.
J Immunol. 1995 May 1;154(9):4778-84.
We previously reported that taurine chloramine (Tau-Cl) inhibits the production of both nitric oxide and TNF-alpha by activated RAW 264.7 cells. The current studies were conducted to gain insight into the mechanisms through which Tau-Cl exerts these effects. RAW 264.7 cells were activated by LPS (10 micrograms/ml) and rIFN-gamma (50 U/ml) in the absence or presence of either 0.8 mM Tau-Cl or taurine. Production of NO and TNF-alpha by RAW 264.7 cells was monitored: NO was measured spectrophotometrically as nitrite and TNF-alpha was measured by ELISA. Cell lysates were analyzed for the inducible form of nitric oxide synthase (iNOS) by Western blot analyses, and TNF-alpha and iNOS mRNAs were assessed by northern blot analyses. Tau-Cl inhibited transcription of the iNOS gene, or some earlier event in the signal transduction pathway, because iNOS protein and iNOS mRNA were undetected in lysates of cells activated in the continuous presence of Tau-Cl. In contrast, steady-state levels of TNF-alpha mRNA increased in the presence of Tau-Cl to at least the same extent as that in untreated activated cells and persisted for a longer period of time. Metabolic labeling experiments demonstrated that Tau-Cl inhibited translation of TNF-alpha mRNA because the presence of the presecretory 26-kDa form and the secreted 17-kDa form of TNF-alpha were greatly reduced in lysates and culture media, respectively, of cells activated in the presence of Tau-Cl. Inhibition of TNF-alpha synthesis by Tau-Cl is not the result of a generalized effect on protein synthesis because the amount of radiolabeled protein precipitated from metabolically labeled cells by TCA was unaffected by Tau-Cl, and cell viability was unaffected. The results of these studies demonstrate that Tau-Cl decreases production of tissue-damaging inflammatory mediators and thus may act as a physiologic modulator of macrophage function.
我们之前报道过,氯胺牛磺酸(Tau-Cl)可抑制活化的RAW 264.7细胞产生一氧化氮和肿瘤坏死因子-α(TNF-α)。开展当前这些研究是为了深入了解Tau-Cl发挥这些作用的机制。在不存在或存在0.8 mM Tau-Cl或牛磺酸的情况下,用脂多糖(LPS,10微克/毫升)和重组干扰素-γ(rIFN-γ,50单位/毫升)激活RAW 264.7细胞。监测RAW 264.7细胞产生一氧化氮和TNF-α的情况:一氧化氮以亚硝酸盐形式通过分光光度法测定,TNF-α通过酶联免疫吸附测定法(ELISA)测定。通过蛋白质印迹分析检测细胞裂解物中诱导型一氧化氮合酶(iNOS)的诱导形式,通过Northern印迹分析评估TNF-α和iNOS信使核糖核酸(mRNA)。Tau-Cl抑制iNOS基因的转录或信号转导途径中的某些早期事件,因为在持续存在Tau-Cl的情况下活化的细胞裂解物中未检测到iNOS蛋白和iNOS mRNA。相比之下,在存在Tau-Cl的情况下,TNF-α mRNA的稳态水平增加,至少与未处理的活化细胞中的增加程度相同,并且持续更长时间。代谢标记实验表明,Tau-Cl抑制TNF-α mRNA的翻译,因为在存在Tau-Cl的情况下活化的细胞的裂解物和培养基中,分别大大减少了分泌前26 kDa形式和分泌的17 kDa形式的TNF-α的存在。Tau-Cl对TNF-α合成的抑制不是对蛋白质合成的普遍影响的结果,因为三氯乙酸(TCA)从代谢标记的细胞中沉淀的放射性标记蛋白质的量不受Tau-Cl影响,并且细胞活力不受影响。这些研究结果表明,Tau-Cl可减少组织损伤性炎症介质的产生,因此可能作为巨噬细胞功能的生理调节剂发挥作用。